Every supplement on the nitric oxide market today shares the same assumption: give the body a precursor and let NOS do the rest. L-arginine, L-citrulline, beetroot nitrate — they all feed into enzymatic pathways that the body is already struggling to run efficiently. My research takes a fundamentally different position.

The precursor problem

The standard model works like this: you consume a precursor, the enzyme converts it, and nitric oxide is produced. Simple in theory. In practice, the enzyme — NOS — becomes progressively less efficient with age, oxidative stress, and metabolic disruption. By the time most people begin supplementing, the very machinery they are relying on has already declined.

• L-arginine: Requires functional NOS to convert. Inconsistent results in older adults are well-documented.
• Beetroot / nitrate: Depends on oral bacteria and gut conversion. Antibiotic use, mouthwash, and gut dysbiosis all reduce efficacy.
• L-citrulline: A step removed — must first convert to arginine, then to NO. More steps, more failure points.

What pathway-independent means in practice

My fermented metabolite delivers bioavailable nitric oxide without routing through any of these enzymatic steps. The fermentation process itself produces the active molecule — meaning the body receives it directly rather than having to manufacture it from a precursor. The practical result is consistency: the benefit does not quietly erode as enzymatic efficiency drops with age.

“We spent two decades asking a single question: what if the body did not need to make the nitric oxide at all? The metabolite is the answer to that question.”

Who benefits most

• Adults over 45 — NOS uncoupling accelerates in this window; precursors become less reliable.
• Metabolic health conditions — oxidative stress from diabetes and hypertension further impairs NOS.
• Athletes in recovery — consistent NO availability supports tissue repair independent of workout-induced oxidative load.

The supplement market will catch up to this eventually. Until then, the distinction between precursor-based and metabolite-based delivery is the most important one a consumer can understand.